Frist Cressey backs One to One Health with $12M to scale AI care.

Frist Cressey Ventures has made a minority growth investment of $12 million into One to One Health, accelerating the rollout of its employer‑sponsored primary care model and the company’s AI clinical tools. The capital will be deployed to expand the provider’s network, deepen virtual and onsite offerings, and accelerate development of its AI-driven clinical platform, Intelligent Care Manager.

Leadership framed the deal as a bet on primary care as the fulcrum for value in employer health. CEO David Kinzler said the firm plans to marry relationship‑based care with real‑time decision support so clinicians can act on the latest member data during visits. The company currently serves more than 650 organisations and over 500,000 members, a scale the new funding aims to multiply.

The investment arrives amid rising employer health costs — industry forecasts point to cost pressures approaching 10% growth in 2026 — and growing interest from self‑insured employers in onsite and integrated virtual primary care. One to One Health markets a combined care model that, it reports, can generate savings as large as $4,000 per employee per year by reducing utilisation downstream and improving management of chronic conditions.

Intelligent Care Manager, the platform highlighted in the transaction, supplies clinicians with real‑time clinical intelligence at the point of care. The system aims to surface care gaps, prioritize preventive interventions and suggest evidence‑based actions — a workflow enhancement intended to improve outcomes while reducing unnecessary referrals and specialist spend.

The deal partners One to One with an investor team that brings healthcare operational know‑how and sector relationships. Co‑Founder Bill Frist, M.D. of Frist Cressey Ventures emphasised the investor view that accessible, personalised primary care supports both patient experience and system affordability. The company’s board also includes high‑profile backers who see primary care as foundational to broader health system performance.

Operational metrics sit at the centre of One to One’s story: its TextCare® concierge benefit launched in 2021 reports an industry‑leading Net Promoter Score of 94 and client retention of 99%. The business model ties engagement to savings by combining high utilisation of community‑based services with data‑driven care pathways that reduce costly acute episodes.

Analysts tracking employer health innovation say the transaction reflects two broader trends: growing investor appetite for integrated primary care platforms that combine tech with delivery, and a move by employers toward risk‑bearing arrangements that prioritise prevention. For One to One, the $12M injection should finance market expansion and productisation of clinical AI — but success will hinge on demonstrating consistent, replicable ROI across diverse employer populations.

For peers and purchasers in the corporate health space, the deal signals both competition and validation: primary care operators that can pair trusted human relationships with live clinical intelligence are increasingly attractive to capital and to employers seeking measurable cost control and member engagement.